Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001640334-26-000368
Filing Date
2026-02-24
Accepted
2026-02-24 08:01:07
Documents
64
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K artl_10k.htm   iXBRL 10-K 1537149
2 DESCRIPTION OF SECURITIES artl_ex41.htm EX-4.1 25593
3 CONSENT artl_ex231.htm EX-23.1 1502
4 CERTIFICATION artl_ex311.htm EX-31.1 12835
5 CERTIFICATION artl_ex312.htm EX-31.2 12604
6 CERTIFICATION artl_ex321.htm EX-32.1 5276
7 CERTIFICATION artl_ex322.htm EX-32.2 5055
  Complete submission text file 0001640334-26-000368.txt   5231301

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA artl-20251231.xsd EX-101.SCH 47782
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE artl-20251231_lab.xml EX-101.LAB 291305
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE artl-20251231_cal.xml EX-101.CAL 45042
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE artl-20251231_pre.xml EX-101.PRE 246652
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE artl-20251231_def.xml EX-101.DEF 148493
67 EXTRACTED XBRL INSTANCE DOCUMENT artl_10k_htm.xml XML 541249
Mailing Address 505 LOMAS SANTA FE, SUITE 160 SOLANA BEACH CA 92075
Business Address 505 LOMAS SANTA FE, SUITE 160 SOLANA BEACH CA 92075 858-925-7049
ARTELO BIOSCIENCES, INC. (Filer) CIK: 0001621221 (see all company filings)

EIN.: 331220924 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38951 | Film No.: 26667597
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)